Prostatic Neoplasms Completed Phase 2 Trials for Cabazitaxel (DB06772)

Also known as: Neoplasm,Prostatic / Neoplasms, Prostatic / Prostatic Neoplasm

IndicationStatusPhase
DBCOND0028225 (Prostatic Neoplasms)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01576029Continued Treatment With Docetaxel Versus Switch to Cabazitaxel After Minor Prostate Specific Antigen Response to Docetaxel in Patients With Castration-Resistant Metastatic Prostate CancerTreatment